The goal of this application is to stake Northwestern University's place as part of a multi-institution consortium (the North American Star Consortium) that will join the National Cancer Institute's (NCI) Experimental Therapeutics Clinical Trials Network (ETCTN). The aim off that network is efficient and comprehensive conduct of early phase clinical trials of NCI Investigational New Drug (IND) agents. The ETCTN is designed to assure the availability of investigators and programs with expertise in early drug development and translational research for this purpose.
|Effective start/end date||3/1/20 → 2/28/26|
- University Health Network (Toronto) (410013075//2UM1CA186644-06)
- National Cancer Institute (410013075//2UM1CA186644-06)
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.